estradiol-delivered cytotoxin prodrug therapy (Spear Therapeutics)

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug Nameestradiol-delivered cytotoxin prodrug therapy (Spear Therapeutics)
Drug Alias NameSpecific P450 Enzyme Activated Drug Release (Spear Therapeutics)SPEAR cancer prodrug therapy (Spear Therapeutics)DMU-317
ClassificationSmall molecules > Prodrug > Directed prodrug therapy
Mechanisms of ActionBioreducible cytotoxin
TargetsUpdating
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSpear Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSpear Therapeutics
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A